1256935-40-6

Basic information

• Product Name: potassium hydrogen difluoride
• Synonyms: potassium hydrogen difluoride
• CAS NO: 1256935-40-6
• Molecular Weight: 78.103
• Mol File: 1256935-40-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: potassium hydrogen difluoride(CAS DataBase Reference)
• NIST Chemistry Reference: potassium hydrogen difluoride(1256935-40-6)
• EPA Substance Registry System: potassium hydrogen difluoride(1256935-40-6)

Safety Data

• Hazardous Substances Data: 1256935-40-6(Hazardous Substances Data)

Downstream Products

• 120120-28-7 4-(triethylsiloxy)-4-(trifluoromethyl)-2,5-cyclohexadien-1-one 
• 88538-48-1 3-chloro-pyridazine-6-sulphonamide 
• 374564-35-9 potassium 4-bromophenyltrifluoroborate 
• 1350898-79-1 potassium 2,6-difluoro-4-{[2-oxo-2-(pentafluorophenoxy)ethoxyimino]-methyl}phenyltrifluoroborate 
• 85465-50-5 2-fluoro-1-(3-methoxyphenyl)ethan-1-one 
• 454182-00-4 6-methoxy-pyridazine-3-sulfonyl fluoride 

Relevant articles and documents

Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors

This invention relates to novel sulfonyl pyridazinone compounds useful as aldose reductase inhibitors in the treatment or prevention of certain complications arising from diabetes mellitus, pharmaceutical compositions comprising the sulfonyl pyridazinone, pharmaceutical compositions comprising a combination of the sulfonyl pyridazinone together with a second pharmaceutical agent, therapeutic methods comprising the administration of the sulfonyl pyridazinone compounds, therapeutic methods comprising the administration of the sulfonyl pyridazinone compounds in combination with a second pharmaceutical agent and compounds useful as intermediates for preparing the sulfonyl pyridazinone compounds of this invention.

Sulfonyl pyridazinone compounds as therapeutic agents for ischemic tissue damage

This invention relates to therapeutic methods for treatment or prevention of tissue damage resulting from ischemia in mammals.